A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Kidney International

• Publication date

  2015-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ki.2015.215PMID 26221751
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory activation and recovering BKV‐specific immunity correlate with self‐limited BKV replication after renal transplantation

  2014cited by this paper
• The role of CD4+ T cells in BKV-specific T cell immunity

  2014cited by this paper
• Treatment of BK virus‐associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single‐center experience

  2013cited by this paper
• Pathology of Resolving Polyomavirus‐Associated Nephropathy

  2013cited by this paper
• Phenotypic and Functional Characterization of Circulating Polyomavirus BK VP1-Specific CD8+ T Cells in Healthy Adults

  2013cited by this paper
• Polyomavirus BK Replication in De Novo Kidney Transplant Patients Receiving Tacrolimus or Cyclosporine: A Prospective, Randomized, Multicenter Study

  2012cited by this paper
• Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin

  2012cited by this paper
• Preferential Expansion of Human Virus-Specific Multifunctional Central Memory T Cells by Partial Targeting of the IL-2 Receptor Signaling Pathway: The Key Role of CD4+ T Cells

  2012cited by this paper
• Simultaneous Isolation of CD8+ and CD4+ T Cells Specific for Multiple Viruses for Broad Antiviral Immune Reconstitution After Allogeneic Stem Cell Transplantation

  2011cited by this paper
• Antigen‐specific T cell responses to BK polyomavirus antigens identify functional anti‐viral immunity and may help to guide immunosuppression following renal transplantation

  2011cited by this paper
• BK-VP3 as a New Target of Cellular Immunity in BK Virus Infection

  2011cited by this paper
• The Polyomavirus BK Large T-Antigen-Derived Peptide Elicits an HLA-DR Promiscuous and Polyfunctional CD4+ T-Cell Response

  2011cited by this paper
• BK Virus-Specific T Cells for Use in Cellular Therapy Show Specificity to Multiple Antigens and Polyfunctional Cytokine Responses

  2011cited by this paper
• BK polyomavirus infection and nephropathy: the virus–immune system interplay

  2011cited by this paper
• Novel Approach for Improved Assessment of Phenotypic and Functional Characteristics of BKV-Specific T-Cell Immunity

  2011cited by this paper
• BK Virus‐Specific Immunity Kinetics: A Predictor of Recovery From Polyomavirus BK‐Associated Nephropathy

  2011cited by this paper
• Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients

  2011cited by this paper
• 1-O-Hexadecyloxypropyl Cidofovir (CMX001) Effectively Inhibits Polyomavirus BK Replication in Primary Human Renal Tubular Epithelial Cells

  2010cited by this paper
• Adoptive T‐Cell Therapy of a Lung Transplanted Patient with Severe CMV Disease and Resistance to Antiviral Therapy

  2009cited by this paper
• Inhibition of Polyomavirus BK-Specific T-Cell Responses by Immunosuppressive Drugs

  2009cited by this paper
• Generation of HCMV-specific T-cell Lines From Seropositive Solid-organ-transplant Recipients for Adoptive T-cell Therapy

  2009cited by this paper
• An OPTN Analysis of National Registry Data on Treatment of BK Virus Allograft Nephropathy in the United States

  2009cited by this paper
• Sustained BK Viruria as an Early Marker for the Development of BKV-Associated Nephropathy: Analysis of 4128 Urine and Serum Samples

  2009cited by this paper
• T-cell quality in memory and protection: implications for vaccine design

  2008cited by this paper
• EBV Latent Membrane Proteins (LMPs) 1 and 2 as Immunotherapeutic Targets: LMP-Specific CD4+ Cytotoxic T Cell Recognition of EBV-Transformed B Cell Lines1

  2008cited by this paper
• IL-10 Is Excluded from the Functional Cytokine Memory of Human CD4+ Memory T Lymphocytes1

  2007cited by this paper
• Polyomavirus BK‐Specific Cellular Immune Response to VP1 and Large T‐Antigen in Kidney Transplant Recipients

  2007cited by this paper
• Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities.

  2007cited by this paper
• Functional Characterization of BK Virus-Specific CD4+ T Cells with Cytotoxic Potential in Seropositive Adults

  2007cited by this paper
• Identification and isolation of murine antigen‐reactive T cells according to CD154 expression

  2007cited by this paper
• HLA Type‐Independent Method to Monitor Polyoma BK Virus‐Specific CD4+ and CD8+ T‐Cell Immunity

  2006cited by this paper
• BK virus: opportunity makes a pathogen.

  2005cited by this paper
• Direct access to CD4+ T cells specific for defined antigens according to CD154 expression

  2005cited by this paper
• HLA type‐independent generation of antigen‐specific T cells for adoptive immunotherapy

  2005cited by this paper
• Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection.

  2004cited by this paper
• Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1.

  2004cited by this paper
• The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.

  2004cited by this paper
• Detection of antigen‐specific T cells by cytokine flow cytometry: the use of whole blood may underestimate frequencies

  2003cited by this paper
• Polyomavirus BK.

  2003cited by this paper
• Polyomavirus BK Nephropathy: A (Re‐)emerging Complication in Renal Transplantation

  2002cited by this paper
• Characterization of CD4+ CTLs Ex Vivo1

  2002cited by this paper
• Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay

  2001cited by this paper
• Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

  2001cited by this paper
• Functional Characterization of CD8+ Antigen‐Specific Cytotoxic T Lymphocytes after Enrichment Based on Cytokine Secretion: Comparison with the MHC‐Tetramer Technology

  2000cited by this paper
• Human polyoma virus-associated interstitial nephritis in the allograft kidney.

  1999cited by this paper
• Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

  1999cited by this paper
• Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

  1999cited by this paper
• Infection in organ-transplant recipients.

  1998cited by this paper
• 4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses

  1997cited by this paper
• Infectious disease complications of renal transplantation.

  1993cited by this paper

• Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation

  2025cites this paper
• NaCl and urea modulate CD8+ T cell survival, renal accumulation, and response to BK virus

  2025cites this paper
• Adaptive immune response and evasion strategies of BK virus.

  2025cites this paper
• Urine-derived renal tubular epithelial cells resemble functional characteristics of professional antigen-presenting cells and can directly induce BKV-specific T cell responses

  2025cites this paper
• The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation

  2024cites this paper
• Control of BKPyV-DNAemia by a Tailored Viro-Immunologic Approach Does Not Lead to BKPyV-Nephropathy Progression and Development of Donor-Specific Antibodies in Pediatric Kidney Transplantation

  2024cites this paper
• Cellular Immunity Against BK Polyomavirus in Kidney Transplant Recipients: A Comprehensive Review

  2024cites this paper
• The effect of the BK polyomavirus large T antigen on the function and maturity of the CD4+ T cell subsets in kidney transplant recipients.

  2023cites this paper
• Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients

  2022cites this paper
• Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study

  2022cites this paper
• In vitro and In vivo evidence that the switch from calcineurin to mTOR-inhibitors may be a strategy for immunosuppression in Epstein-Barr-Virus-associated post-transplant lymphoproliferative disorder.

  2022cites this paper
• Temporary hold of mycophenolate boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients

  2022cites this paper
• BK Polyomavirus Nephropathy in Kidney Transplantation: Balancing Rejection and Infection

  2021cites this paper
• Intravenous immunoglobulins do not prove beneficial to reduce alloimmunity among kidney transplant recipients with BKV‐associated nephropathy

  2021cites this paper
• Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity

  2021cites this paper
• The Magnitude and Functionality of SARS-CoV-2 Reactive Cellular and Humoral Immunity in Transplant Population Is Similar to the General Population Despite Immunosuppression

  2021cites this paper
• A possible role of immunopathogenesis in COVID-19 progression

  2020cites this paper
• COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a++

  2020cites this paper
• Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient

  2020cites this paper
• CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients

  2020cites this paper
• Mucosal associated invariant T cells are differentially impaired in tolerant and immunosuppressed liver transplant recipients

  2020cites this paper
• Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease.

  2020cites this paper
• COVID-19 progression is potentially driven by T cell immunopathogenesis

  2020cites this paper
• BKV Clearance Time Correlates With Exhaustion State and T-Cell Receptor Repertoire Shape of BKV-Specific T-Cells in Renal Transplant Patients

  2019influential citation
• The TreaT-Assay: A Novel Urine-Derived Donor Kidney Cell-Based Assay for Prediction of Kidney Transplantation Outcome

  2019cites this paper
• BK polyomavirus-specific antibody and T-cell responses in kidney transplantation: update.

  2019cites this paper
• BK virus-induced renal allograft nephropathy.

  2018cites this paper
• BK Polyomavirus Immune Response With Stress on BK-Specific T Cells.

  2018cites this paper
• Simultaneous detection of decidual Th1/Th2 and NK1/NK2 immunophenotyping in unknown recurrent miscarriage using 8-color flow cytometry with FSC/Vt extended strategy

  2017cites this paper
• BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies

  2017cites this paper
• Inhibition of polyomavirus DNA replication by nucleotide analogs

  2017cites this paper
• Increased Frequency of BK Virus-Specific Polyfunctional CD8+ T Cells Predict Successful Control of BK Viremia After Kidney Transplantation

  2017cites this paper
• Eine verbesserte Strategie für das Monitoring der BKV-spezifischen zellulären Immunität bei Nierentransplantierten (Sponsor: Novartis Pharma GmbH, Nürnberg)

  2016cites this paper